EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Sensitivity of a Modified Quaking‐Induced Conversion Diagnostic Test for the Broad Detection of Sporadic and Inherited Prion Diseases: A Retrospective Study

Jennifer Myskiw iD, Rebecca Fox, Dominic M S Kielich, Lise Lamoureux, Melanie Leonhardt, Olivia Nykvist, Jessy A Slota iD, Kristen Avery, Clark Phillipson, Kathy Frost, Sharon Simon, Brian S Appleby und 2 weitere

Annals of Neurology · 2026-05 · 99 (5) · 1303-1314

DOI: 10.1002/ana.78162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 26.01.2026. Verfasst von Jennifer Myskiw und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mycobacteriology, Vector-borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Prion Diseases, Creutzfeldt-Jakob Syndrome, Prion Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Quaking‐induced conversion (QuIC) tests, which detect prion‐seeding activity in cerebrospinal fluid (CSF), have markedly advanced the antemortem diagnosis of prion diseases such as Creutzfeldt‐Jakob disease (CJD). These tests provide high diagnostic accuracy and enable timely differentiation from other rapidly progressive neurodegenerative disorders. However, a key limitation of current QuIC tests are the reduced sensitivity in detecting inherited prion diseases and rare sporadic subtypes, including variably protease‐sensitive prionopathy (VPSPr). To address this gap, we evaluated a simplified QuIC test, end‐point QuIC (EP‐QuIC), incorporating a novel recombinant prion protein substrate derived from the North American deer mouse ( Peromyscus maniculatus ).

Methods

The diagnostic performance of the modified QuIC test was evaluated using CSF samples from 61 sporadic CJD, 50 inherited prion disease, and 5 VPSPr cases.

Results

EP‐QuIC with the deer mouse substrate achieved 96.6% sensitivity (111/116) and 100% specificity (35/35), outperforming both standard EP‐QuIC (87.1%) and next‐generation (IQ‐CSF) real‐time‐QuIC (72.4%) across the same cohort. Notably, this enhanced assay detected inherited mutations, such as D178N, that were previously undetectable with existing diagnostic tests.

Interpretation

These findings demonstrate that adapting EP‐QuIC with an optimized substrate, termed enhanced sensitivity QuIC (ES‐QuIC), significantly improves diagnostic performance for inherited and atypical prion diseases. By expanding the diagnostic reach of QuIC tests, this study strengthens antemortem surveillance, reduces reliance on postmortem confirmation, and improves opportunities for early intervention and clinical trial enrollment, particularly for genetic cases most likely to benefit from emerging therapeutic strategies. ANN NEUROL 2026;99:1303–1314

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prion DiseasesCreutzfeldt-Jakob SyndromePrion ProteinsAnimalsRetrospective StudiesSensitivity and SpecificityHumansPeromyscusPrionsFemale

Substanzen

Prion ProteinsPrions

Autor:innen und Institutionen

  • Mycobacteriology, Vector-borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Department of Medical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • National Prion Disease Pathology Surveillance Center, Case Western Reserve University School of Medicine, Cleveland, OH.
  • Department of Neurology, Psychiatry, and Pathology, Case Western Reserve University School of Medicine/University Hospitals Cleveland Medical Center, Cleveland, OH.

ORCID-Profile: Jennifer Myskiw, Jessy A Slota, Stephanie A Booth

Zitieren

APA

Myskiw, J., Fox, R., Kielich, D. M. S., Lamoureux, L., Leonhardt, M., Nykvist, O., Slota, J. A., Avery, K., Phillipson, C., Frost, K., Simon, S., Appleby, B. S., Bailey-Elkin, B. A., & Booth, S. A. (2026). Enhanced Sensitivity of a Modified Quaking‐Induced Conversion Diagnostic Test for the Broad Detection of Sporadic and Inherited Prion Diseases: A Retrospective Study. Annals of Neurology, 99(5), 1303-1314. https://doi.org/10.1002/ana.78162

Vancouver

Myskiw J, Fox R, Kielich DMS, Lamoureux L, Leonhardt M, Nykvist O, et al. Enhanced Sensitivity of a Modified Quaking‐Induced Conversion Diagnostic Test for the Broad Detection of Sporadic and Inherited Prion Diseases: A Retrospective Study. Annals of Neurology. 2026;99(5):1303-1314. doi:10.1002/ana.78162

BibTeX
@article{Myskiw2026,
  author = {Myskiw, Jennifer and Fox, Rebecca and Kielich, Dominic M S and Lamoureux, Lise and Leonhardt, Melanie and Nykvist, Olivia and Slota, Jessy A and Avery, Kristen and Phillipson, Clark and Frost, Kathy and Simon, Sharon and Appleby, Brian S and Bailey-Elkin, Ben A and Booth, Stephanie A},
  title = {Enhanced Sensitivity of a Modified Quaking‐Induced Conversion Diagnostic Test for the Broad Detection of Sporadic and Inherited Prion Diseases: A Retrospective Study},
  journal = {Annals of Neurology},
  year = {2026},
  volume = {99},
  number = {5},
  pages = {1303--1314},
  doi = {10.1002/ana.78162}
}
Kostenlos starten →